Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

M.D. Anderson Cancer Center · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
recurrent plasma cell myeloma, refractory plasma cell myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 811933
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.